2021 US Oncology Testing Market Assessment: Shares and Sales Segment Forecasts By Assay

April 2021 | 40 pages | ID: 27A277D9F32DEN
Venture Planning Group

Abstracts

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.

The report is available by section, and can be customized to specific information needs and budget.

This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Contains 25 pages and 7 tables

Contents

BUSINESS ENVIRONMENT

1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
  a. Chronic Illness
  b. Disease Incidence
  c. Susceptibility to Iatrogenesis
  d. Multiple Illness Cases
11. Laboratory Regulations

MARKET STRUCTURE

1. Centralized Testing
  a. Hospitals
  b. Commercial/Private Laboratories
2. Decentralized Testing
  a. Physician Offices/Group Practices
  b. Cancer Clinics
  c. Point of Care Testing
  d. Other Decentralized Testing Locations

MARKET SIZE, GROWTH, AND MAJOR SUPPLIERS’ MARKET SHARES

LIST OF TABLE

Test Volume Forecast by Market Segment Sales Forecasts by Market Segment
AFP Testing: Market Shares of Major Suppliers
CA 15-3/27-29 Testing: Market Shares of Major Suppliers
CA 19-9 Testing: Market Shares of Major Suppliers
CEA Testing: Market Shares of Major Suppliers
PSA Testing: Market Shares of Major Suppliers